Microbio Co., Ltd. (TPEX:4128)

Market Cap	13.70B
Revenue (ttm)	1.77B
Net Income (ttm)	-1.11B
Shares Out	588.17M
EPS (ttm)	-1.89
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000,593
Average Volume	1,365,636
Open	23.45
Previous Close	23.30
Day's Range	23.25 - 23.70
52-Week Range	20.00 - 45.48
Beta	0.56
RSI	51.67
Earnings Date	Aug 11, 2025

About Microbio

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is base...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2000
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4128

Financial Performance

In 2024, Microbio's revenue was 1.72 billion, an increase of 8.26% compared to the previous year's 1.59 billion. Losses were -1.10 billion, -6.70% less than in 2023.